Trials / Withdrawn
WithdrawnNCT01417299
The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are studying the impact of RPh201 on chronic vegetative patients. RPh201 has been reported to induce neuronal regeneration in animal models. Evaluation will be done by combining clinical /behavioral assessment with fMRI studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | RPh201 | Patients will receive 400 microliter s.c., of RPh201 twice a week for 3 months |
| DIETARY_SUPPLEMENT | saline | Patients will receive 400 microliter s.c., of saline twice a week for 3 months |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2017-10-01
- Completion
- 2018-10-01
- First posted
- 2011-08-16
- Last updated
- 2015-09-22
Source: ClinicalTrials.gov record NCT01417299. Inclusion in this directory is not an endorsement.